poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing
- 1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
- 2RNA Bioinformatics and High-Throughput Analysis, Friedrich Schiller University Jena, Jena, Germany
- 3Methodology and Research Infrastructure, MF1 Bioinformatics, Robert Koch Institute, Berlin, Germany
Corrigendum on
poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing
by Brandt, C., Krautwurst, S., Spott, R., Lohde, M., Jundzill, M., Marquet, M., and Hölzer, M. (2021). Front. Genet. 12:711437. doi: 10.3389/fgene.2021.711437
In the original article, we neglected to include the funder “Ministry for Economics, Sciences and Digital Society of Thuringia (TMWWDG), DigLeben-5575/10-9 to Sebastian Krautwurst and Mara Lohde”. A correction has been made to the the funding section:
“This work received financial support from the Ministry for Economics, Sciences and Digital Society of Thuringia (TMWWDG), under the framework of the Landesprogramm ProDigital (DigLeben-5575/10-9) and by grants from the Federal Ministry of Education and Research (Grant No. 01KX2021).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Nextflow, bioinformatics, coronavirus – COVID-19, lineages, docker, SARS-CoV-2, pipeline, nanopore sequencing
Citation: Brandt C, Krautwurst S, Spott R, Lohde M, Jundzill M, Marquet M and Hölzer M (2022) Corrigendum: poreCov - An Easy to Use, Fast, and Robust Workflow for SARS CoV-2 Genome Reconstruction via Nanopore Sequencing. Front. Genet. 13:875644. doi: 10.3389/fgene.2022.875644
Received: 14 February 2022; Accepted: 15 February 2022;
Published: 14 March 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Brandt, Krautwurst, Spott, Lohde, Jundzill, Marquet and Hölzer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Christian Brandt, christian.brandt@med.uni-jena.de